News About: Pharm. Industry
49 companies organizes consultative body for promotion of biopharmaceutical industy
A total of 49 Korean biotech and pharmaceutical companies, including 20 multinational drug manufactures here, set up a new consultative body on March 18 to develop the local biopharmaceutical industry as one of Korea’...
Drugmakers calls for two-way sanctions
The government needs to step up its fight against chronic illegal rebate practices whereby doctors and pharmacists receive money from drug makers in return for prescribing or recommending their products, according to ...
Choong-wae seeks 1 trillion won sales with new cancer treatment
Choong-wae Pharm announces that it will embark on phase I study of “CWP-231A”, a first-in-class candidate anticancer medicine targeting Wnt proteins.
The company said it will seek the approval of clinical studies b...
FTC to look into drugmakers and wholesalers
Korea’s antitrust regulator has embarked on looking into the pricing collusion of pharmaceutical companies and wholesalers following the recent drug bidding failure in Seoul National University Hospital.
The Fair T...
Daewoong, Boehringer Ingeheim Korea sign strategic partnership agreement
Daewoong Pharm and Boehringer Ingeheim Korea (BIK) announced on March 15 that the two companies have signed a strategic partnership agreement to let Daewoong market BIK’s seven leading OTC (over-the-counter) drugs in ...
Government to support for local pharmaceutical industry
The Ministry of Health, Welfare and Family Affairs announced on March 14 that it will set up a consultative body for the development of the domestic pharmaceutical industry within this month as part of its efforts to ...
Generic prices to fall by 46% over original brands
When a number of newly licensed generic drugs for GSK “Hepsera” (adefovir) or SK Chemicals “Joins” will get listed for insurance coverage in the months to come, their prices of the corresponding original drugs will be...
KPMA’s emergency committee striving to publicize contributing roles of local pharmaceutical firms
The pharmaceutical industry has never really had a good reputation, either here or elsewhere. Behind the life-curing business are heavy lobbying, dirty politics and giant rebates for favorite buyers, all of which is r...
Oscotec wins Europe patent for BT-201 for treatment of arthritis
Oscotec Inc., a local bone-related biopharmaceutical company, said on March 10 that it has recently won a patent of its anti-arthritis drug, BT-201, from the European Patent Office for the treatment of arthritis
Th...
Kyungdong Pharm’s Ryu to head KPMA emergency committee
The Korea Pharmaceutical Manufacturers Association announced on March 11 it has unanimously elected Ryu Duck-hee as a head of the association’s newly established emergency committee after ex-president Auh June-sun res...
